Clinical Pharmacology During Pregnancy (Record no. 7009)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 04183nam a22002537a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240305192449.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 220607b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0123860083 |
| International Standard Book Number | 9780123860088 |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | dlc |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.3 |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Donald R. Mattison |
| 9 (RLIN) | 38587 |
| 110 ## - MAIN ENTRY--CORPORATE NAME | |
| 9 (RLIN) | 38588 |
| 245 ## - TITLE STATEMENT | |
| Title | Clinical Pharmacology During Pregnancy |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | London |
| Name of publisher, distributor, etc. | Academic Press |
| Date of publication, distribution, etc. | 2012 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 488 pages |
| 505 ## - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Contents:<br/><br/>1 Introduction<br/><br/>2 Physiologic Changes During Pregnancy<br/><br/>3 Impact of Pregnancy on Maternal Pharmacokinetics of Medications<br/><br/>4 Medications and the Breastfeeding Mother<br/><br/>5 Fetal Drug Therapy<br/><br/>an Evolving Therapeutic Concept<br/><br/>7 What is Sufficient Evidence to Justify a Multicenter Phase 3 Randomized Controlled Trial in Obstetrics?<br/><br/>8 Ethics of Clinical Pharmacology Research in Pregnancy<br/><br/>15 Substance Use Disorders<br/><br/>16 Diabetes in Pregnancy<br/><br/>17 Cardiovascular Medications in Pregnancy<br/><br/>18 Antidepressants in Pregnancy<br/><br/>19 Uterine Contraction Agents and Tocolytics<br/><br/>20 Antenatal Thyroid Disease and Pharmacotherapy in Pregnancy<br/><br/>21 Dermatological Medications and Local Therapeutics<br/><br/>22 Vitamins Minerals Trace Elements and Dietary Supplements<br/><br/><br/>9 Pharmacogenomics in Pregnancy<br/><br/>10 Analgesics and AntiInflammatory General and Local Anesthetics and Muscle Relaxants<br/><br/>11 The Management of Asthma During Pregnancy<br/><br/>12 Updated Guidelines for the Management of Nausea and Vomiting of Pregnancy and Hyperemesis Gravidarum<br/><br/>13 Clinical Pharmacology of AntiInfectives During Pregnancy<br/><br/>14 Chemotherapy in Pregnancy<br/><br/>23 Herbs and Alternative Remedies<br/><br/>24 Envenomations and Antivenoms During Pregnancy<br/><br/>25 Gastrointestinal Disorders<br/><br/>Index<br/> |
| Title | Clinical Pharmacology During Pregnancy |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Clinical Pharmacology During Pregnancy is written for clinicians, physicians, midwives, nurses, pharmacists and other medical professionals directly involved in the care of women during pregnancy. This book focuses on the impact of pregnancy on drug disposition and also includes coverage of treatments for diseases of specific body systems as well as essential content on dosing and efficacy.<br/><br/>The broad range of this book encompasses analgesics, antiasthmatics, antidepressants, heart and circulatory drugs, vitamins and herbal supplements, and more. Topics in chemotherapy and substance abuse are covered, as are research issues, including clinical trial design and ethical considerations.<br/><br/>Uses an evidence-based approach for therapeutics during pregnancy<br/>Includes a summary of specific medications by indication with up-to-date information on dosing and efficacy in pregnancy for the given indication |
| Expansion of summary note | Common terms and phrases: acid activity addiction administration adverse agents alcohol anesthesia anesthetic antidepressants antivenom associated asthma atenolol birth weight breast cancer breast milk breastfeeding buprenorphine calcium changes clearance Clin Pharmacol clinical clonidine concentrations congenital corticosteroids cross the placenta decreased delivery depression digoxin disease disorders dose drug efficacy envenomation enzymes excreted exposure FDA category fetal fetus gestational diabetes glucose glyburide Gynecol half-life hemodynamic hepatic human hypertension hypothyroidism increased risk indomethacin infants infections inhibitors insulin intravenous lactation malformations maternal medications Metab metabolism metformin methadone mother nancy neonatal nifedipine non-pregnant ObstetGynecol Obstetrics opioid oral outcomes perinatal pharmacodynamic pharmacokinetics pharmacological placenta plasma postpartum potential preeclampsia preg pregnancy category pregnant patients pregnant women prenatal preterm labor protein binding receptor recommended renal reported result safety serum side effects symptoms syndrome teratogenic therapeutic therapy third trimester thyroid tion tocolysis tocolytic toxicity treat treatment trials trimester trimester of pregnancy urine uterine vitamin weeks |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| General subdivision | Medical / Pharmacology |
| 9 (RLIN) | 27230 |
| General subdivision | Medical / Gynecology & Obstetrics |
| 9 (RLIN) | 26832 |
| General subdivision | Medical › Pharmacology |
| 9 (RLIN) | 27231 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | ddc |
| Koha item type | E-BOOKS |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection | Home library | Current library | Shelving location | Date acquired | Total checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 06/07/2022 | 615.3 | EBS11482 | 06/07/2022 | 06/07/2022 | E-BOOKS |